A randomised phase III study in advanced oesophageal carcinoma to compare dysphagia in patients treated with radiotherapy versus chemo-radiotherapy.

People with cancer of the oesophagus (gullet) often have trouble swallowing. Radiotherapy can help improve this problem. Using chemotherapy together with radiotherapy may work better but has more side effects. This trial will determine if it is better to use radiotherapy by itself or together with chemotherapy.

Primary Sponsor

Trans Tasman Radiation Oncology Group (TROG)

Collaborating Groups

NCI CTG (ES 2)

Final Accrual

220

Trial Chairperson

Dr Michael Penniment, Royal Adelaide Hospital, SA

Trial Contact

sonya.stephens@health.sa.gov.au

Clinical Trial Registration

Related Post

16 September, 2025

Expanded access to radiation therapy Talking Book to support Aboriginal and Torres Strait Islander consumers

LATEST NEWS: 16 September 2025 A ‘Talking Book’ which

26 August, 2025

Welcome to new TROG committee members and thank you to long-serving members

LATEST NEWS: 26 August 2025 The TROG Scientific Committee